July 2, 2001 Roches clinical trial 1 Levovirin 
Author Message
 July 2, 2001 Roches clinical trial 1 Levovirin

Roche licenses ICN's potential anti-hepatitis C drug
July 2, 2001 Monday 02:36 AM Eastern Time
Roche licenses ICN's potential anti-hepatitis C drug

    Roche Holding AG said it has licensed ICN Pharmaceuticals Inc's
rights for levovirin, a potential second-generation compound against
hepatitis C.
    Under this licensing agreement, Roche will pay ICN a one-off
licensing fee, as well as milestone payments.
    If levovirin is successfully developed and granted regulatory
approval Roche will also grant ICN royalties, Roche said.
    In return, Roche will be in charge of all future development
activities and  have global marketing rights with the exception of
some Eastern European countries.
    Roche is currently developing Pegasys, another anti-hepatitis C
drug, and  its use in combination with levovirin is forecast to set
new standards in this therapeutic area, it said.
    Phase I clinical trials with levovirin began in Feb 2001, while
Pegasys phase III clinical trials were reported last month, Roche

    de/jfr For more information and to contact AFX: www.afxnews.com


Copyright (c) 2000

Fri, 19 Dec 2003 22:28:58 GMT
 [ 1 post ] 

 Relevant Pages 

1. Roches Pegasys Approved Switzerland August 7th/2001

2. Clinical Research - Clinical Trials India - Phase I/IIa clinical trials - CRO

3. Clinical Research - Phase I/IIa clinical trials - Clinical Trials India - CRO

4. Compounds and methods tested in clinical trials, alone or in combination (July 2008)

5. Hepatitis C- 500 Subject Full Clinical Trials + 100 Subject Full Clinical Double Blind Trial Study

6. RTM: Takahashi: fluoride water with more cancer in 23/36 body sites July 2001 rmforall

7. Taliban praise Bin Ladin - July 22, 2001

8. ALS Digest #887 (19 July 2001)

9. Ladies Home Journal article July 2001

10. LUPUS-1 Klempner and HLA-DQB1*0602, RI Conference, July 2001- from the CLD study

Powered by phpBB® Forum Software